Becker Daniel J. 4

What Happened

• Daniel J. Becker, a director of Zura Bio Ltd (ZURA), received a derivative award covering 51,000 shares on June 17, 2026. The transaction is reported as a grant/award (derivative) with a reported price of $0.00, indicating an option-style award rather than an open-market purchase or sale. No immediate cash value or sale occurred.

Key Details

• Transaction date: 2026-06-17; Form 4 filed: 2026-06-22 (filed 5 calendar days after the grant; this may be later than the typical 2-business-day Form 4 filing requirement).
• Security/amount: Option award for 51,000 shares; reported price $0.00 (derivative).
• Vesting: The option vests in twelve substantially equal monthly installments over one year beginning June 17, 2026. Any remaining unvested portion will vest the day before the next annual shareholders’ meeting, subject to continued service (see footnote F1).
• Shares owned after transaction: Not specified in the filing.
• Footnote: F1 describes the monthly vesting schedule and accelerated vesting provision tied to the next annual meeting, conditioned on continued service.

Context

• This is a grant of an equity award (not an outright purchase or sale). Such awards are common as compensation for directors and do not necessarily indicate a purchase-based bullish signal or an immediate liquidity event. The award does not appear to have been exercised or sold concurrently.